IDENTIFICATION OF A 251 GENE EXPRESSION SIGNATURE THAT CAN ACCURATELY DETECT M. TUBERCULOSIS IN PATIENTS WITH AND WITHOUT HIV CO-INFECTION.

Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection.

Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection.

Blog Article

BackgroundCo-infection with tuberculosis (TB) is the fleshlight automatique leading cause of death in HIV-infected individuals.However, diagnosis of TB, especially in the presence of an HIV co-infection, can be limiting due to the high inaccuracy associated with the use of conventional diagnostic methods.Here we report a gene signature that can identify a tuberculosis infection in patients co-infected with HIV as well as in the absence of HIV.MethodsWe analyzed global gene expression data from peripheral blood mononuclear cell (PBMC) samples of patients that were either mono-infected with HIV or co-infected with HIV/TB and used support vector machines to identify a gene signature that can distinguish between the two classes.

We then validated our results using publically available gene expression data from patients mono-infected with TB.ResultsOur analysis successfully identified a 251-gene signature that accurately distinguishes patients co-infected with HIV/TB from those infected with HIV only, with an overall accuracy of 81.4% (sensitivity = 76.2%, specificity = 86.

4%).Furthermore, we show that our 251-gene signature can also accurately distinguish patients with active TB in the absence of an HIV infection from both patients with a latent TB infection and healthy controls (88.9-94.7% accuracy; 69.

2-90% sensitivity and 90.3-100% specificity).We also demonstrate that the expression levels of the 251-gene signature diminish as a correlate of the length of TB treatment.ConclusionsA 251-gene signature eagles head coach hoodie is described to (a) detect TB in the presence or absence of an HIV co-infection, and (b) assess response to treatment following anti-TB therapy.

Report this page